Arquer Diagnostics
Dean represents Esperante Ventures, a significant investor in Arquer. He has an MBA from ENPC Business School, Paris. Following 10 years with the Ferring Pharmaceuticals group in global operations and business development management, he has led Esperante Ventures since 2004, building and growing an investment portfolio of pharmaceutical and diagnostics companies in North America, Europe, and Israel with 4 successful exits to date.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Arquer Diagnostics
Arquer Diagnostics is a dynamic, female-led, and UK-based company working at the cutting-edge of cancer diagnostics. It is their mission to transform how patients are diagnosed with cancer and then monitored throughout their treatment journey.